AlphaQuest LLC Sells 27,100 Shares of Alignment Healthcare, Inc. $ALHC

AlphaQuest LLC trimmed its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 92.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,240 shares of the company’s stock after selling 27,100 shares during the quarter. AlphaQuest LLC’s holdings in Alignment Healthcare were worth $39,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Royal Bank of Canada increased its stake in shares of Alignment Healthcare by 92.6% in the first quarter. Royal Bank of Canada now owns 92,379 shares of the company’s stock valued at $1,720,000 after buying an additional 44,413 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Alignment Healthcare by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,557 shares of the company’s stock worth $1,109,000 after acquiring an additional 2,594 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Alignment Healthcare by 79.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 972,715 shares of the company’s stock worth $18,112,000 after acquiring an additional 429,703 shares during the last quarter. Woodline Partners LP acquired a new position in Alignment Healthcare in the 1st quarter valued at approximately $2,142,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Alignment Healthcare by 16.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 307,655 shares of the company’s stock valued at $5,729,000 after acquiring an additional 44,452 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

ALHC has been the topic of a number of recent research reports. Zacks Research lowered shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 28th. KeyCorp reaffirmed an “overweight” rating and set a $28.00 target price on shares of Alignment Healthcare in a report on Thursday, January 22nd. UBS Group upped their price target on Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, January 14th. JPMorgan Chase & Co. increased their price target on Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Finally, Piper Sandler lifted their price objective on Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 6th. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $23.32.

Alignment Healthcare Stock Performance

Shares of ALHC opened at $20.19 on Monday. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The firm’s fifty day simple moving average is $20.90 and its two-hundred day simple moving average is $18.13. Alignment Healthcare, Inc. has a 12 month low of $11.63 and a 12 month high of $23.87. The stock has a market capitalization of $4.04 billion, a P/E ratio of -168.25, a price-to-earnings-growth ratio of 5.14 and a beta of 1.16.

Insider Activity

In related news, President Dawn Christine Maroney sold 282,070 shares of the company’s stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $18.74, for a total transaction of $5,285,991.80. Following the sale, the president owned 1,385,167 shares in the company, valued at $25,958,029.58. This represents a 16.92% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Robert L. Scavo sold 69,541 shares of the firm’s stock in a transaction that occurred on Monday, December 29th. The stock was sold at an average price of $18.74, for a total value of $1,303,198.34. Following the sale, the insider directly owned 503,014 shares of the company’s stock, valued at $9,426,482.36. This represents a 12.15% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 2,120,938 shares of company stock valued at $41,655,670 in the last ninety days. 6.60% of the stock is owned by company insiders.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.